We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Zytronic Plc | LSE:ZYT | London | Ordinary Share | GB0006971013 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 55.00 | 50.00 | 60.00 | 55.00 | 55.00 | 55.00 | 0.00 | 08:00:27 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Magnetc,optic Recordng Media | 8.61M | -1.56M | -0.1539 | -3.57 | 5.59M |
Date | Subject | Author | Discuss |
---|---|---|---|
09/1/2024 09:28 | Something to chew on in the light of the loss of sales and marketing director/personnel during the financial year and other market changes described in the report: *Sales by financial year Market % FY23 FY22 Percentage Change (%) Vending 30.2% 2.6 3.6m -27.78% Gaming 27.9% 2.4 4.7m -48.94% Industrial14.0% 1.2 1.6m -25.00% Financial12.8% 1.1 1.2m -8.33% Signage 7.0% 0.6 0.6m 0.00% Other 8.1% 0.7 0.6m 16.67% Total 100.0% 8.6 12.3m -30.08% *Open Opportunities Market % Volume CPLV(£m) % Vending 30.9% 174 36.9 53.79% Gaming 5.7% 32 12 17.49% Industrial27.5% 155 4.6 6.71% Financial3.5% 20 3.7 5.39% Signage 16.3% 92 3.5 5.10% Other 16.1% 91 7.9 11.52% Total 100.0% 564 68.6 100.00% CPLV = Customer projected lifetime value Innovation – cost and benefit: The engineering and innovation prowess is evident. However, I wonder how much of this work falls into the category of “an answer looking for a commercial question”. a. I’m not a believer in “Build it and they will come” – but neither would I presume to think that Mark Cambridge is that naïve. b. The public-facing aspects of the ZYT marketing is underwhelming. The web-site overhaul is now being addressed at long last. However, the videos of the “new” innovations seem theoretical instead of illustrating delivered specific commercial examples. I hope this too is addressed. c. The 2022 annual report is extremely informative and a key statement from MC was to point out the converting opportunities to sales follows a “well-reported historical average two-year timeframe”. This is expanded upon in the 2023 report today. The tables summarised above perhaps give some indication of the changes in sales mix expectations. When I have time later, I will get GPT4 to summarise Mr Cambridge's "ramble" to extract what might be the key factors of interest to investors. Senior management: The newly appointed chair, Dr Potts does not seem to have been successful in leading the Guralp group which has substantial accumulated losses and only one significant profitable year in the last 6. It is hard to understand the reason for bringing him on board. Will Henry Spain buy on this dip? DYOR | cliffpeat | |
09/1/2024 08:37 | My main concern is how viable is the core product? Is there enough demand at a price they need? There's no doubt if they can get back to profit that this share price is a real bargain. But can they? | kiwihope | |
09/1/2024 08:30 | Henry Spain won't be pleasedSuspect they will keep addingIf it was a take over target before, it must be now - assets, cash, no debt and global leading IP .... NRI | value viper | |
09/1/2024 08:27 | There are very few positives when reading the results. For many years a decent dividend was paid. The payment of a dividend has now been discontinued. Will Zytronic recover from this poor performance? I am not selling my ZYT shares and will continue to hold. | crystball1 | |
09/1/2024 08:05 | It's not great is itShares getting duly hit now I seeDon't forget the tangible assets So cash and assets worth more than mkt capSo business, IP etc remains totally in for free I believe Strategic review underway - selling business presumably will be part of this I would guessPainful 55p to sell | value viper | |
09/1/2024 08:00 | Over half the market cap in cash, let us hope we can build from this base, of course someone might take it out...... | chrisdgb | |
09/1/2024 07:54 | FY results make somber reading. Management seems on top of the situation but are they able to recover? Start of 2024 doesn't sound great... | kiwihope | |
18/12/2023 17:34 | Little trading today so seems everyone waiting for the Jan announcement | cerrito | |
18/12/2023 11:14 | Not very happy with decrease in cash of£0.7m in the six months but will have to reserve judgement until we see how much of this was due to capex referred to in the interims. I see that revenue H2 was £3.9m, sobering to think that in the corresponding half year in 2019 it was £10.6m. LBITDA has to be seen in context of the increased interest income and that in H1 they had a tax credit. We await the January news, which hopefully will indicate a clear steer from the new Chairman, with interest and in my case a dose of trepidation. | cerrito | |
18/12/2023 07:59 | Pretty much as expected I would say..... | chrisdgb | |
15/12/2023 17:14 | Good to see Market Harborough increasing their position. The mind boggles as to where the share price would be without them. | cerrito | |
12/12/2023 09:30 | Still no results today. Interesting. | boonkoh | |
11/12/2023 13:12 | @Ceritto Mark Perry is Director of ZDL (trading company) not ZYT Results notice was 7th Dec last year with prelims announced on the 13th so approx a week behind schedule | the squire at oakley hall | |
11/12/2023 12:42 | Results should be out? Was this time last year.Also they normally announce the publish date and the IMC meeting date in advance.Something unusual brewing. Thought it would be a profit warning to come, but that shouldn't impact results and IMC.Possibility there's some M&A happening in the background and they want to tie it all up to announce at the same time as results?That would explain why no major shareholder buy/sell RNS in the past month or so... | boonkoh | |
10/12/2023 09:14 | The new chair, Dr Christopher Potts, has been executive chairman of Guralp Holdings Ltd for 9 years. The March 2022 consolidated balance sheet show accumulated losses of £12.5m and only one truly profitable year in the last 6. I hope that the due diligence before appointment identified his key strengths that will help ZYT achieve positive momentum. | cliffpeat | |
10/12/2023 08:50 | @Cerrito The (undated) "news" item of Mark Perry's elevation from sales manager to sales director does not appear to have been notified to Companies House - so I guess it's a commercial but not legal designation. Also, being "excited" to announce it and him being "thrilled" with the promotion is a bit "tik-toky" in my view. I am excited to learn whether they are climbing back from the recent problems and hope to be thrilled by news of a larger order book and positive outlook:) | cliffpeat | |
10/12/2023 08:18 | All seems eerily quiet here. No news since the May 18 IMC meeting. A flatlining share price.Nothing really on the commercial website except to say they will be in Barcelona in January and have a new sales director. I see the financial calender talks about year end results in December, and hopefully this week as we would not want them to bury bad news over Christmas. | cerrito | |
29/11/2023 09:11 | For absolutely no reason I can see. | gdjs100 | |
29/11/2023 07:50 | Nexteq has been very weak........ | chrisdgb | |
20/11/2023 19:13 | Well it will now be the full year results assume before the end of the year that we await. | value viper | |
13/10/2023 15:34 | Hhmm - you would hope that shipping out to Vegas may have yielded something other than I assume cost | value viper | |
11/10/2023 09:07 | @ValueViper 5-7 October - see (badly needs a refresh) website: and on "X" and two short videos on YouTube (recommend playback at x1.5 speed :) Couldn't find any commercially interesting update on this expensive show - disappointing. | cliffpeat | |
11/10/2023 08:09 | Believe have been presenting products in Las Vegas maybe last week Still so quiet here | value viper |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions